Skip to main content


Edited by Dr Claude Martin

This series of articles in Critical Care has not been sponsored. All articles have undergone the journal’s standard peer review process overseen by the Series Editor, with final decisions made by the Editor in Chief. The Series Editor and Editor in Chief declare no competing interests.

  1. Cardiovascular failure is one of the central therapeutic problems in patients with severe infection. Although norepinephrine is a potent and, in most cases, highly effective vasopressor agent, very high dosage...

    Authors: Martin W Duenser and Walter R Hasibeder

    Citation: Critical Care 2004 9:134

    Content type: Commentary

    Published on:

  2. Vasopressin (antidiuretic hormone) is emerging as a potentially major advance in the treatment of septic shock. Terlipressin (tricyl-lysine-vasopressin) is the synthetic, long-acting analogue of vasopressin, a...

    Authors: Anne Delmas, Marc Leone, Sébastien Rousseau, Jacques Albanèse and Claude Martin

    Citation: Critical Care 2004 9:212

    Content type: Review

    Published on:

  3. On one side, brain dysfunction is a poorly explored complication of sepsis. On the other side, brain dysfunction may actively contribute to the pathogenesis of sepsis. The current review aimed at summarizing t...

    Authors: Tarek Sharshar, Nicholas S Hopkinson, David Orlikowski and Djillali Annane

    Citation: Critical Care 2004 9:37

    Content type: Review

    Published on: